Oncology – Page 22

A Proactive Approach to Ovarian Cancer: The New ESGO Consensus on Opportunistic Salpingectomy

By MedXY 02/09/2026

The European Society of Gynaecological Oncology (ESGO) has released new consensus statements advocating for opportunistic salpingectomy—removing fallopian tubes during unrelated surgeries—to significantly reduce ovarian cancer risk without compromising hormone health.

news Oncology Urology

Low Baseline PSA Predicts Exceptional Long-Term Safety: A 20-Year Paradigm Shift in Prostate Cancer Screening

By MedXY 02/09/2026

A 20-year cohort study shows that baseline PSA levels in men aged 45-70 are highly predictive of long-term prostate cancer risk, with PSA <1.0 ng/mL indicating a very low 20-year incidence of 3.3%, supporting extended screening intervals for low-risk individuals.

news Oncology

Opportunistic Bilateral Salpingectomy Reduces Serous Ovarian Cancer Risk by Nearly 80 Percent

By MedXY 02/09/2026

A large-scale population study confirms that removing fallopian tubes during unrelated pelvic surgeries reduces serous ovarian cancer risk by 78%, providing robust evidence for its use as a primary prevention strategy against high-grade serous carcinoma.

news Oncology

Hidden Reservoirs: Six Decades of Autopsy Data Reveal the Growing Burden of Undiagnosed Cancer

By MedXY 02/09/2026

A 66-year Japanese autopsy study reveals a significant reservoir of undiagnosed latent cancers, highlighting rising multiple primary cancer rates and substantial over-prevalence in prostate and thyroid tissues compared to clinical data, emphasizing the need to balance detection with overdiagnosis risks.

news Oncology Public Health

Beyond the Bill: Hope and Social Support as Vital Buffers Against Cancer-Related Financial Toxicity

By MedXY 02/09/2026

A multisite study reveals that financial toxicity significantly reduces life satisfaction in cancer patients. However, hopefulness and social support act as critical mediators, suggesting that integrating psychosocial resilience training with financial assistance can improve patient outcomes.

news Oncology Pediatrics

Does Stage Explain It All? The BENCHISTA Study Reveals Persistent Survival Gaps in Pediatric Oncology

By MedXY 02/09/2026

The BENCHISTA study analyzes survival disparities in six childhood solid tumors across 27 countries, revealing that while stage at diagnosis influences outcomes, significant international survival variations persist for Ewing sarcoma and medulloblastoma even after stage adjustment, suggesting the need for broader healthcare system improvements.

news Oncology Public Health

Pandemic Care Disruptions Linked to Significant Decline in Short-Term Cancer Survival and 17,000 Excess Deaths

By MedXY 02/09/2026

A population-based cohort study using SEER-21 data reveals that patients diagnosed with cancer during 2020 and 2021 experienced significantly lower 1-year cause-specific survival rates compared to prepandemic trends, resulting in an estimated 17,390 excess cancer-related deaths.

news Oncology Public Health

Mapping the European Cancer Landscape: A 1.7 Million Patient Study Reveals Survival Gaps and Comorbidity Patterns

By MedXY 02/07/2026

A large-scale federated study of 1.7 million European patients highlights significant variations in cancer survival and comorbidity profiles, emphasizing the role of real-world data and the OMOP-CDM framework in benchmarking oncological outcomes and identifying clinical prodromes.

news Oncology

Beyond the Incessant Ovulation Hypothesis: How Menopausal Status and Birth Cohort Reshape Ovarian Cancer Risk

By MedXY 02/06/2026

A massive cohort study of 2.2 million women reveals that ovarian cancer risk factors vary significantly by menopausal status and birth year. While early menarche and low parity remain universal risks, the protective benefits of breastfeeding and oral contraceptives appear specific to premenopausal women.

Gastroenterology news Oncology

Time-Varying Risks in Colorectal Adenoma Recurrence: Why Histology and Demographics Demand a Personalized Surveillance Calendar

By MedXY 02/05/2026

A massive cohort study reveals that colorectal adenoma recurrence risk is not static; high-grade dysplasia, villous histology, obesity, and sex-based factors exhibit distinct time-varying patterns, necessitating a shift toward personalized, long-term surveillance strategies.

Dermatology news Oncology

Agent Orange Exposure and Acral Melanoma: Uncovering Non-Ultraviolet Risk Factors in the US Veteran Population

By MedXY 02/05/2026

A large-scale study within the VA health system identifies Agent Orange exposure as a significant risk factor for acral melanoma, while highlighting distinct clinical profiles and a paradoxical inverse association with smoking compared to other cutaneous melanomas.

Dermatology news Oncology

Nivolumab Redefines Long-Term Outcomes in Resected High-Risk Melanoma: 9-Year Insights from CheckMate 238

By MedXY 02/05/2026

The final 9-year analysis of the CheckMate 238 trial confirms that adjuvant nivolumab provides a sustained recurrence-free survival advantage over ipilimumab in patients with resected high-risk melanoma, with 44% of patients remaining recurrence-free nearly a decade after treatment.

news Oncology

Palbociclib Extends Progression-Free Survival in HR+/HER2+ Metastatic Breast Cancer: Insights from the PATINA Trial

By MedXY 02/02/2026

The Phase 3 PATINA trial demonstrates that adding palbociclib to maintenance anti-HER2 and endocrine therapy significantly improves progression-free survival in HR+/HER2+ metastatic breast cancer patients, increasing the median duration from 29.1 to 44.3 months, despite higher rates of neutropenia.

news Oncology Otorhinolaryngology

Camrelizumab Plus Chemotherapy Sets a New Five-Year Survival Benchmark in Recurrent or Metastatic Nasopharyngeal Carcinoma

By MedXY 01/30/2026

A secondary analysis of the CAPTAIN-1st trial reveals that adding camrelizumab to first-line chemotherapy significantly improves five-year overall survival in RM-NPC, with a 37.8% survival rate and notable benefits linked to rapid EBV DNA clearance.

news Oncology Otorhinolaryngology

The Precision Gap: Evaluating Sentinel Lymph Node Biopsy in Head and Neck Merkel Cell Carcinoma

By MedXY 01/30/2026

This article examines the clinical accuracy of Sentinel Lymph Node Biopsy for head and neck Merkel cell carcinoma, highlighting a significant false-negative rate and identifying risk factors that necessitate more personalized treatment strategies for this aggressive skin cancer.

Internal Medicine news Oncology

Low-Dose Aspirin and Cancer Mortality in Older Adults: Long-Term ASPREE Results Challenge Previous Paradigms

By MedXY 01/30/2026

A 10-year follow-up of the ASPREE trial reveals that low-dose aspirin does not reduce cancer incidence in adults aged 70 and older, but is associated with increased cancer-related mortality, challenging long-held assumptions about aspirin's chemopreventive benefits in geriatric populations.

news Oncology Radiology

Proton Therapy Redefines the Standard of Care for Nasopharyngeal Carcinoma: Insights from a Landmark Case-Control Study

By MedXY 01/29/2026

A comprehensive case-control study published in The Lancet Regional Health - Americas highlights how Intensity-Modulated Proton Therapy (IMPT) significantly reduces toxicities and improves quality of life for nasopharyngeal carcinoma patients compared to traditional IMRT.

news Oncology Otorhinolaryngology

Intensity-Modulated Proton Therapy Reduces Acute Toxicity While Maintaining Oncologic Equivalence in Nasopharyngeal Carcinoma: A Five-Year Case-Control Analysis

By MedXY 01/29/2026

A case-control study comparing IMPT and IMRT for nasopharyngeal carcinoma shows that IMPT significantly reduces grade 2+ acute toxicities without compromising long-term survival or local-regional control, suggesting a superior therapeutic index during the acute treatment phase.

news Oncology Public Health

Mammography Screening and Mortality: A 40-Year European Population-Based Evaluation Shows Shift to Early-Stage Detection

By MedXY 01/28/2026

A massive 21-country study confirms that mammography screening has significantly shifted breast cancer detection toward earlier stages, contributing to a substantial decline in mortality across Europe, though treatment advances also play a critical role.

Dermatology news Oncology

Activating EGFR L858R Variants Linked to Syndromic Generalized Acanthosis Nigricans and Pulmonary Risk: A New Clinical Entity

By MedXY 01/27/2026

This study identifies activating EGFR L858R variants as the genetic basis for a syndrome featuring generalized acanthosis nigricans and lung nodules, highlighting the efficacy of EGFR inhibitors in treating both cutaneous and systemic manifestations.